Clarus Financial Technology

SEF: A Year In Review

SEF 1st Birthday

It’s been a year since the first SEF executed trade.  Whether you’ve been subscribing to our data services, peeking in on the freeview versions of these tools, or just reading our blogs, you probably have a good idea about how its all gone down over the past year.  I thought it worthwhile to share a general update on what we’ve seen over this year.

A BRIEF HISTORY OF TIME (IN SEF)

So how would you summarize the past year?  Let me take a crack at it.

August 2013
September 2013
October 2013
November 2013
December 2013
CFTC US Person Summary
January 2014
February 2014
March 2014
April 2014
May 2014
June 2014
July & August 2014
September 2014

A BLOG ABOUT A BLOG

For any detailed commentary on any of the above topics, look no further than my blog.  Given the 1st birthday of SEF’s, I have taken the opportunity to play with excel a bit and come up with the following timeline showing all of my blogs to date.  We at Clarus have pushed out a couple hundred blogs over the past 18 months, myself accounting for 48 of them, mostly on the topic of SEF’s.  What is interesting to me is how clearly you can see the weekly blogs I did up until Week 23, at which point the amount of topical information in SEF-land began to taper.

SEF Blog Timeline

SHOW ME THE TRENDS OVER THE YEAR

The best way to spot some of the trends that emerged over the past year is with charts generated in SEFView.  Lets have a look.

Overall SEF Activity

We can make out some of these events described above.  Eyeballing the chart below showing all activity spanning IRD, FX and Credit, you can make out the Feb 17 MAT weeks and the highlights in the month of September.

52 weeks of SEF Activity – ex-FRA and OIS
Look at Each Asset Class

Looking at the data by asset class, we can see the vast majority is in IRD, which has had some steady growth.  FX and Credit, while paling in comparison, have also shown similar growth.

SEF Activity by Asset Class by Week
Look at D2C vs D2D

Here you can readily make out that the growth has been in the client SEFs.  Interdealer activity has plateau’d.

SEF Activity by Legacy SEF Type
Look at Futures

Whittling the data down to just USD Vanilla swaps and their USD Swap Future cousins, we can also see that swap futures have not presented a real threat.  Any blips would seem to be the quarterly contract rolls.

USD Vanilla Swaps – OTC & Futures

WHAT LIES AHEAD

I will wrap up with some predictions for the next 12 months.

Order Book

There have been a few press releases over the previous months speaking about the growth in some of the IDB order books.  I am a believer that electronic order books will ultimately be the sources of liquidity for the liquid products that comprise 60-70% of the market.  There is just no fundamental reason this wouldn’t be the case.  In other asset classes, it took a while, but when it happened, the shift occurred and was permanent.  The same will surely happen.  Within the next 12 months?  I would say yes.

More MAT products

So you have come to learn that trading your spot starting swap has to be done on SEF.  This required lots of pain, be it legal, operational, technical, but the investments have been made.  Now that we have arrived, you have to ask yourself – does a 4-day forward start swap really mean you have to pick up a phone?  Another MAT submission will happen, and it will be justifiable.

MAC & Futures

There will always be the bespoke nature of the swaps market.  However I see growth in the standardized MAC contracts as good approximations that yield cost benefits that outweigh the small basis risk.  Further, liquidity providers will prefer these products as cheaper to margin and process.  The CDS market had a big bang, but I project a slow bang in rates in these standardized contracts.  I think that shift will be visible within the next year.  The next logical progression is into trading these products as futures.  I’m not as bullish on this happening within the next 12 months, but I do see growth in futures within this coming year, however I do not believe it will constitute more than a handful of percent.  Yet.

Focus on Margin

Over the past year there has been lots of expenditure by firms on compliance.  I see compliance costs taking a turn back towards earth.  What’s next is capital.  I’ve been shocked to find that firms, both buyside and sellside, have been generally oblivious to the costs associated with collateralizing their OTC derivatives with a central counterparty.  For some, its because they haven’t historically had to pay margin.  For others, its because their cost of capital has been low in the current low-rate environment.   All we need is for rates to inch up, and that suddenly constitutes a doubling or trebling of funding costs for many firms.  Desks will quickly be forced to behave smarter about their funding costs, and margin will be of primary importance.

SUMMARY

Crazy year.  No other year quite like it in the past 20 years of OTC derivatives.  I have a hard time seeing how the next 12 months could trump this one.

Stay informed with our FREE newsletter, subscribe here.

Exit mobile version